Michael Pride

Michael Pride has over two decades of experience at Pfizer, where roles include Vice President, Executive Director, and Senior Director, leading a team focused on the development, qualification, and validation of assays for vaccine programs, particularly in bacterial vaccines targeting Clostridium difficile and pneumococcal pneumonia. Prior to Pfizer, Michael Pride held positions at MD Anderson Cancer Center, including Director, Associate Director, and Postdoctoral Fellow. Academic credentials include a Postdoctoral Fellowship in Immunology from the University of Texas M.D. Anderson Cancer Center, a Ph.D. in Experimental Pathology/Immunology from the State University of New York at Buffalo-Roswell Park Cancer Center, and a B.S. in Biology/Philosophy from Boston College.